Jade Biosciences JBIO
NASDAQ JBIO
$15.08 -0.05 (-0.33%)
As of: Oct 22, 2026 · 9:52 AM EDT

Jade Biosciences (JBIO) Asset Utilization Ratio (2021 - 2026)

Updated

Analysis

Jade Biosciences (JBIO) Asset Utilization Ratio (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,148.13 Bn 1,116.72 Bn 19.71 Bn 0.62
2 Johnson & Johnson 630.09 Bn 548.62 Bn 17.26 Bn 0.49
3 AbbVie 498.99 Bn 472.10 Bn 12.70 Bn 0.47
4 Merck 374.92 Bn 329.30 Bn 12.21 Bn 0.52
5 Novartis Ag 300.99 Bn 264.98 Bn 11.24 Bn 0.46
6 Astrazeneca 264.63 Bn 238.32 Bn 12.86 Bn 0.51
7 Amgen 239.15 Bn 194.55 Bn 7.24 Bn 0.40
8 Gilead Sciences 192.23 Bn 166.43 Bn 6.22 Bn 0.58
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 0.31
10 Jade Biosciences 920.42 Mn -387.21 Mn - 0.03
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.03
Mar 31, 2026 0.03
Dec 31, 2025 0.03
Sep 30, 2025 0.03
Jun 30, 2025 0.03
Mar 31, 2025 0.05
Dec 31, 2024 0.05
Sep 30, 2024 0.05
Jun 30, 2024 0.06
Mar 31, 2024 0.05
Dec 31, 2023 0.04
Sep 30, 2023 0.03
Jun 30, 2023 0.03
Mar 31, 2023 -0.04
Dec 31, 2022 0.89
Sep 30, 2022 0.83
Jun 30, 2022 0.77
Mar 31, 2022 0.78
Dec 31, 2021 0.00
Sep 30, 2021 0.00
API Access

Jade Biosciences Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=JBIO&period=max&api_key=YOUR_API_KEY